TNF biology, pathogenic mechanisms and emerging therapeutic strategies - Wikidata - wikimedia - TriplyDB

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

http://www.wikidata.org/entity/Q26776492

about

Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Placental DAPK1 and autophagy marker LC3B-II are dysregulated by TNF-α in a gestational age-dependent manner.Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.CD40L and Its Receptors in Atherothrombosis-An Update Macrophage inducible C-type lectin (Mincle) recognizes glycosylated surface (S)-layer of the periodontal pathogen Tannerella forsythia.Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment.Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.CNS Demyelination with TNF-α Blockers TNFα Increases RANKL Expression via PGE₂-Induced Activation of NFATc1 Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers.Dose-Dependent Responses of I3C and DIM on T-Cell Activation in the Human T Lymphocyte Jurkat Cell Line.Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.Selected cytokine pathways in rheumatoid arthritis.Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway.More to Life than NF-κB in TNFR1 Signaling Tristetraprolin as a Therapeutic Target in Inflammatory Disease Skin under Tnf influence: how regulatory T cells work against macrophages in psoriasis.Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.The Role of Cytokines in the Development of Atherosclerosis.Pro-inflammatory cytokines mediate GPCR dysfunction.Modulating inflammation and neuroprotection in multiple sclerosis.Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.Layered defense: how mucus and tight junctions seal the intestinal barrier.Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response.Tumor necrosis factor prevents Candida albicans biofilm formation.The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions Functional Detection of TNF Receptor Family Members by Affinity-Labeled Ligands.Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFα, induces robust activation and a phenotypic switch of ILC3.DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway MeCP2 and CTCF: enhancing the cross-talk of silencers.Rheumatoid arthritis fibroblast-like synoviocytes co-cultured with PBMC increased peripheral CD4+ CXCR5+ ICOS+ T cell numbers.Rheumatoid arthritis: Do TNF inhibitors influence lymphoma development?

P2860

Q28077020-729CF4C5-D542-44A3-BE64-3B6F88AE7081 Q33624763-F85A6F35-D700-4F29-8922-3A22A54656DF Q33678668-830E5743-9C19-4AAF-BCD4-6F195A453C19 Q33719360-4257405D-6785-4953-ABE0-D2A9175FD8E9 Q33814059-91DCB167-3D6C-45B0-8F4E-C5023C0C298F Q36298474-2BA598AC-DC26-4EE9-825F-7955D7D4B714 Q37202363-F88E35D5-2376-4116-AEE2-0D0F0B527B9E Q37338091-947B6EA4-39B8-4173-B727-F6C9BF39CF10 Q37522385-A50969F2-685B-4439-8F70-8C746A3F5579 Q37538505-9A40D7B6-B420-43A4-92A8-C9398C3EEA33 Q37719132-92BFB71F-183D-4EED-A3AA-B9BA8642AAF4 Q37729020-0C400ED4-84DC-4644-A896-C21B46E1C931 Q38616681-8E566C75-7ECA-4EEC-B967-CB076D9D2688 Q38645887-402881E1-8D31-487F-99A9-6B62077127E1 Q38696936-1CE45C36-6456-467B-89A2-FCFB27862016 Q38748557-93D03679-31A3-4EE5-B0E8-AE8A9F0F3535 Q38755912-AFFB159B-6D09-4CF0-869A-9C05D922B6D6 Q38836998-D2027609-AA78-4451-8C34-11373374A47A Q38841171-D80C30A2-EB5F-40AE-8243-8B02EE346290 Q38850832-411F78A8-C6BE-4256-B7BB-530C8D8D5A59 Q38899361-705AF670-3862-48DC-AB93-6F67BE8C8CD8 Q38922458-73D5F8DB-361A-4DF0-B489-6B7231BEC83C Q38982301-6052982A-0AE4-47EC-A58F-012844AF3E07 Q39012136-28FBDE37-BDD1-4CEC-A8F1-78010F256385 Q39028288-9F2F5E1B-02B0-4ED1-B65E-8F469D7A58BC Q39070066-5C0BD6AD-40FF-4FB6-8DAA-FB7EEBF68452 Q39350409-0CFFAB3D-C109-4B75-AA34-A76C44CF89B7 Q39413866-4287A7A9-87E7-4FC1-B042-476C07872B20 Q39434367-61E85FD9-B8BE-4176-84B9-4FD1F5CC6FFB Q40164030-75C34C16-122E-4BE7-AA9B-F8C901FC40AB Q40235960-F9354476-19C7-4F4A-BB5D-5C03F3B5E859 Q40876695-76F7598C-99FC-48EA-8A18-2B4AD13130B2 Q41017195-27FE788F-A7A3-4A37-821A-7F558AB222FB Q41170077-86BCE6C3-F268-4BF8-BF30-648F1746EA13 Q41192295-C217C46F-3EC0-4856-BF30-B12B9CC1B876 Q41323743-19E53D35-4527-40C0-B13F-A8595D558A6B Q41418721-BD894221-2DC8-4682-97C3-EF21F35793E0 Q45303510-768C2ED4-80F8-498A-8C29-7E25B391E669 Q46317472-C8D24BFF-37A0-413E-BB27-3A6EBDD5D4A7 Q46429984-038EE60C-0713-4887-B081-5EB343B6B5B3

P2860

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

http://www.wikidata.org/entity/Q26776492

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@ast

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@en

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@nl

type

label

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@ast

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@en

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@nl

prefLabel

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@ast

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@en

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@nl

P1433

Q26776492-BFFCA7E0-89C4-4CB3-B814-FB5DDA20576C

P1476

Q26776492-8882B96C-35D2-4D00-A31C-A957829DB441

P2093

Q26776492-4D237E16-F8C2-4AE0-83C8-F8FEB471EC65

P2860

Q26776492-02978B5F-9045-4790-9952-52FE66063138

Q26776492-058304F9-9ECB-423B-9BA0-7C224C279AFC

Q26776492-076A3C4F-3AA9-4D27-B6BF-70E3F0CC468C

Q26776492-07ED2FB2-2B26-4D98-9B7A-86120480F51B

Q26776492-1056FC82-2A72-4067-A760-178C43ABCFAC

Q26776492-10D3D41B-A4F7-49F5-BD4B-0F3B774822EA

Q26776492-13472655-1959-4370-9317-33EF7D9C6898

Q26776492-14377828-62C9-4F8A-8E10-76BD5CA91514

Q26776492-1920E8EB-5AE2-47B8-9C4E-0ED04BEE54E7

Q26776492-1D3BCF8A-6F90-4CBC-B863-7F3A4F50D5E7

P2888

Q26776492-597F7152-DCA3-48FC-99FC-C3CD1A0E6B2D

P304

Q26776492-0A1BBC35-1886-4463-9FF6-4C0EB19F5BCA

P31

Q26776492-B836C6F0-9B15-4304-9F88-08AFC2394E7F

P3181

Q26776492-C53C4F23-E049-4F6E-84D4-59C780F176B5

P356

Q26776492-F4064766-E4B6-4274-8477-783BE3802AFE

P407

Q26776492-2B5CB0D4-4804-4AAD-8321-7DD80A364C0D

P433

Q26776492-F6EE9008-4A96-4550-888E-864BB7B7B10F

P478

Q26776492-D45917E4-AAF0-43DC-A91C-AB80E9784999

P50

Q26776492-69ED10F9-E32B-4444-85F0-B8925FB52AD0

P577

Q26776492-2DF7147A-6359-4B59-BCB3-7F470DB96C72

P6179

Q26776492-22A98176-7CFD-43FB-9E95-0C3F16405FA4

P698

Q26776492-52379CF2-7EFB-4047-9935-C79350F5D061

P921

Q26776492-53858437-A0BF-4B1E-9041-1764F5EEE761

P932

Q26776492-DF791E49-A527-4F73-8C72-1086DA4E2FDC

P3181

P356

NRRHEUM.2015.169

P1433

Nature Reviews Rheumatology

P1476

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

@en

P2093

Lionel B Ivashkiv

http://www.w3.org/2001/XMLSchema#string

P2860

Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction

OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin

Inactivation of TNF signaling by rationally designed dominant-negative TNF variants

The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation

OTULIN restricts Met1-linked ubiquitination to control innate immune signaling

Linear ubiquitination prevents inflammation and regulates immune signalling

SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex

SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7

P2888

nrrheum.2015.169

P304

49-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3125947

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRRHEUM.2015.169

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

George D. Kalliolias

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051264828

http://www.w3.org/2001/XMLSchema#string

P698

26656660

http://www.w3.org/2001/XMLSchema#string

P921

P932

4809675

http://www.w3.org/2001/XMLSchema#string